Development Partners International (DPI), an investment firm focused on Africa with $2.8 billion in assets under management including co-investments, and CDC Group, the UK’s development finance institution, today announced that an agreement has been signed for KELIX Bio to acquire Pharmaceutical Institute (PHI), a Moroccan-headquartered producer and distributor of generic and therapeutic pharmaceuticals.
Share this post
Morocco: DPI and CDC in pharma deal
Share this post
Development Partners International (DPI), an investment firm focused on Africa with $2.8 billion in assets under management including co-investments, and CDC Group, the UK’s development finance institution, today announced that an agreement has been signed for KELIX Bio to acquire Pharmaceutical Institute (PHI), a Moroccan-headquartered producer and distributor of generic and therapeutic pharmaceuticals.